Therapeutic Implication of Anti‐CTGF in Neointimal Hyperplasia via Regulating Mitochondrial Dysfunction and VSMC Phenotypic Switch

Ae-Rang Hwang, Chang-Hoon Woo, Young Jin Kang

Open source

DOI
10.1155/cdr/5400858
Published
2026-01
Container
Cardiovascular Therapeutics
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/cdr/5400858,
  title = {Therapeutic Implication of Anti‐CTGF in Neointimal Hyperplasia via Regulating Mitochondrial Dysfunction and VSMC Phenotypic Switch},
  author = {Ae-Rang Hwang and Chang-Hoon Woo and Young Jin Kang},
  year = {2026},
  journal = {Cardiovascular Therapeutics},
  doi = {10.1155/cdr/5400858},
  url = {https://doi.org/10.1155/cdr/5400858}
}

RIS

TY  - JOUR
TI  - Therapeutic Implication of Anti‐CTGF in Neointimal Hyperplasia via Regulating Mitochondrial Dysfunction and VSMC Phenotypic Switch
AU  - Ae-Rang Hwang
AU  - Chang-Hoon Woo
AU  - Young Jin Kang
PY  - 2026
JO  - Cardiovascular Therapeutics
DO  - 10.1155/cdr/5400858
UR  - https://doi.org/10.1155/cdr/5400858
ER  - 

APA

Hwang, A., Woo, C., & Kang, Y. J. (2026). Therapeutic Implication of Anti‐CTGF in Neointimal Hyperplasia via Regulating Mitochondrial Dysfunction and VSMC Phenotypic Switch. Cardiovascular Therapeutics. https://doi.org/10.1155/cdr/5400858

Source records